Century Therapeutics, Inc. (IPSC)
Market Closed
14 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 00
+0.06
+3.0928%
$
179.2M Market Cap
- P/E Ratio
- Div Yield
507,594 Volume
-2.04 Eps
$ 1.94
Previous Close 
Want to track IPSC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Century Therapeutics, Inc. (IPSC) Statistics
Valuation metrics
Market Cap 179.2M
Enterprise value 152.93M
Trailing P/E (ttm) -1.87
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 1.72
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.61
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 401.2K
Average volume (90 days) 2.23M
Price summary
52-Week low 0.43
52-Week high 3.04
Beta -
50-Day moving average 2.01
200-Day moving average 2.29
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.38%
Return on equity -0.53%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.53
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.58
Total debt (mrq) -
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 8.28%
Book value per share (mrq) 1.13
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
